Plante Moran Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
11,175
+803
+8% +$21K 0.01% 141
2026
Q1
$291K Buy
10,372
+4,937
+91% +$131K 0.02% 129
2025
Q4
$135K Sell
5,435
-206
-4% -$5.2K 0.01% 202
2025
Q3
$144K Sell
5,641
-1,272
-18% -$31.4K 0.01% 198
2025
Q2
$168K Buy
6,913
+179
+3% +$4.17K 0.01% 178
2025
Q1
$171K Sell
6,734
-252
-4% -$6.59K 0.01% 186
2024
Q4
$185K Sell
6,986
-1,836
-21% -$49.8K 0.02% 181
2024
Q3
$255K Sell
8,822
-875
-9% -$25.5K 0.02% 151
2024
Q2
$271K Sell
9,697
-1,652
-15% -$45.5K 0.03% 140
2024
Q1
$315K Sell
11,349
-5,000
-31% -$139K 0.03% 119
2023
Q4
$471K Sell
16,349
-3,150
-16% -$95.2K 0.05% 88
2023
Q3
$647K Sell
19,499
-8,728
-31% -$309K 0.08% 60
2023
Q2
$1.04M Buy
28,227
+8,879
+46% +$346K 0.12% 44
2023
Q1
$789K Sell
19,348
-3,609
-16% -$156K 0.11% 54
2022
Q4
$1.18M Buy
22,957
+616
+3% +$29.5K 0.17% 42
2022
Q3
$978K Sell
22,341
-1,307
-6% -$63.5K 0.17% 42
2022
Q2
$1.24M Buy
23,648
+5,088
+27% +$259K 0.21% 40
2022
Q1
$961K Sell
18,560
-716
-4% -$37.1K 0.18% 53
2021
Q4
$1.14M Sell
19,276
-2,810
-13% -$139K 0.19% 50
2021
Q3
$950K Sell
22,086
-3,011
-12% -$133K 0.21% 52
2021
Q2
$983K Sell
25,097
-3,285
-12% -$128K 0.24% 50
2021
Q1
$1.03M Sell
28,382
-1,983
-7% -$70.4K 0.28% 46
2020
Q4
$1.12M Buy
30,365
+188
+0.6% +$6.9K 0.35% 41
2020
Q3
$1.05M Sell
30,177
-1,517
-5% -$53.2K 0.37% 39
2020
Q2
$983K Sell
31,694
-1,156
-4% -$39.3K 0.39% 37
2020
Q1
$1.02M Sell
32,850
-3,264
-9% -$111K 0.47% 31
2019
Q4
$1.34M Buy
36,114
+1,857
+5% +$66.1K 0.47% 31
2019
Q3
$1.17M Sell
34,257
-2,758
-7% -$100K 0.34% 47
2019
Q2
$1.52M Sell
37,015
-478
-1% -$19K 0.47% 30
2019
Q1
$1.51M Buy
37,493
+7,207
+24% +$289K 0.47% 29
2018
Q4
$1.25M Buy
30,286
+2,233
+8% +$92.7K 0.44% 34
2018
Q3
$1.17M Sell
28,053
-1,705
-6% -$65.6K 0.38% 34
2018
Q2
$1.02M Sell
29,758
-1,527
-5% -$52.2K 0.52% 39
2018
Q1
$1.05M Buy
31,285
+589
+2% +$20.2K 0.57% 35
2017
Q4
$1.05M Buy
30,696
+346
+1% +$11.8K 0.58% 32
2017
Q3
$1.03M Buy
30,350
+5
+0% +$161 0.61% 32
2017
Q2
$967K Sell
30,345
-4,215
-12% -$133K 0.6% 35
2017
Q1
$1.12M Sell
34,560
-6,528
-16% -$206K 0.68% 28
2016
Q4
$1.27M Buy
41,088
+6,553
+19% +$200K 0.79% 26
2016
Q3
$1.11M Sell
34,535
-10,785
-24% -$361K 0.75% 31
2016
Q2
$1.51M Buy
45,320
+4,562
+11% +$146K 1.1% 16
2016
Q1
$1.15M Buy
40,758
+454
+1% +$13K 0.88% 27
2015
Q4
$1.23M Sell
40,304
-1,928
-5% -$60.7K 0.93% 19
2015
Q3
$1.26M Buy
42,232
+7,516
+22% +$241K 0.99% 19
2015
Q2
$1.1M Buy
34,716
+3,227
+10% +$105K 0.79% 27
2015
Q1
$1.04M Buy
31,489
+953
+3% +$30.3K 0.72% 33
2014
Q4
$902K Buy
30,536
+918
+3% +$26.3K 0.66% 29
2014
Q3
$831K Sell
29,618
-1,289
-4% -$36.2K 0.73% 31
2014
Q2
$870K Buy
30,907
+4,076
+15% +$116K 0.78% 29
2014
Q1
$818K Sell
26,831
-4,104
-13% -$122K 0.89% 27
2013
Q4
$899K Buy
30,935
+6,184
+25% +$180K 0.51% 29
2013
Q3
$675K Sell
24,751
-1,888
-7% -$51.4K 0.41% 33
2013
Q2
$708K Buy
+26,639
New +$736K 0.52% 29

Other funds holding PFE

Plante Moran Financial Advisors's PFE Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its Pfizer (PFE) stake by 7.7% in Q2 2026, buying an estimated $21K and bringing the position to 11,175 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #141.

Plante Moran Financial Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.52M in Q2 2019. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Plante Moran Financial Advisors held 11,175 shares of Pfizer worth $269K as of Q2 2026.
  • Plante Moran Financial Advisors bought 803 Pfizer shares in Q2 2026, an estimated $21K.
  • Pfizer made up 0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #141 holding.
  • Plante Moran Financial Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Plante Moran Financial Advisors's Pfizer position peaked at $1.52M in Q2 2019.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.